Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH-Reference-Cited by-同舟云学术

Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH

Published:2021-11-08 Issue:1 Volume:20 Page:39-47
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J of Thrombosis Haemost

Author:

Roberts Lara N.¹^ORCID,Lisman Ton²^ORCID,Stanworth Simon³⁴⁵,Hernandez‐Gea Virginia⁶,Magnusson Maria⁷⁸,Tripodi Armando⁹,Thachil Jecko¹⁰^ORCID

Affiliation:

1. King’s Thrombosis Centre Department of Haematological Medicine King’s College Hospital London UK

2. Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation Department of Surgery University Medical Center Groningen University of Groningen Groningen the Netherlands

3. Transfusion Medicine NHS Blood and Transplant Oxford UK

4. Department of Haematology Oxford University Hospitals NHS Foundation Trust Oxford UK

5. Radcliffe Department of Medicine University of Oxford and NIHR Oxford Biomedical Research Centre (Haematology) Oxford UK

6. Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic IDIBAPS Red de Enfermedades Hepáticas y Digestivas (CIBEREHD) Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN‐Liver) University of Barcelona Barcelona Spain

7. Department of Pediatrics Clinical Chemistry and Blood Coagulation Research MMK CLINTEC Karolinska Institutet Stockholm Sweden

8. Department of Haematology Karolinska University Hospital Stockholm Sweden

9. IRCCS Ca’ Granda Maggiore Hospital Foundation Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa Milano Italy

10. Department of Haematology Manchester Royal Infirmary Manchester UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jth.15562

Reference68 articles.

1. Global hemostatic status in patients with acute‐on‐chronic liver failure and septics without underlying liver disease

2. Patterns of blood component use in cirrhosis: a nationwide study

3. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases;Northup PG;Hepatology,2021

4. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

5. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periprocedural care, bleeding control and rules for the use of antithrombotics in patients with haemostatic disorders in liver disease;Vnitřní lékařství;2024-09-04

2. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-09

3. Prevention and management of venous thrombosis in patients with cirrhosis;British Journal of Haematology;2024-08-26

4. The historical origins of modern international normalized ratio targets;Journal of Thrombosis and Haemostasis;2024-08

5. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08